Advances in the scientific understanding of Alzheimer’s Disease and the emergence of new Alzheimer’s therapies are casting a new light on the future of screening and diagnosis for Alzheimer’s Disease.
Innovative new tests for Alzheimer’s are now emerging or in development, including innovations in cognitive behavioral assessment, imaging, blood-based testing, and other modalities. They will play a major role in shaping the course of screening, diagnosis, and treatment for Alzheimer’s and dementia services in the coming years.
- This is a hybrid conference with both in-person and virtual participation. View the registration link for more information.
- The forum is open to the public and will be recorded for viewing on the NEHI website.
Kaiser Permanente Center for Total Health, Convergence Center, 700 2nd Street NE, Washington D.C.
View the full webinar here.
Download the webinar slides above.